Friday, January 8, 2010, 11:18am EST - Canadian Markets close in 4 hours and 42 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Alcon Inc. (ACL)

At 11:03 EST: 153.9899 USD  Down 0.2101 (0.14%)  
MORE ON ACL
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
ALCON INC (NYSE:ACL) Delayed quote dataEdit
Last Trade: 153.9899 USD
Trade Time: 11:03AM EST
Change: Down 0.2101 (0.14%)
Prev Close: 154.20
Open: 152.93
Bid: N/A
Ask: N/A
1y Target Est: 173.00
Day's Range: 152.93 - 154.56
52wk Range: 76.03 - 166.71
Volume: 314,963
Avg Vol (3m): 1,010,010
Market Cap: 46.04B
P/E (ttm): 23.48
EPS (ttm): 6.558
Div & Yield: 3.49 (2.26%)
Alcon Inc. (ACL)
1d  5d  3m  6m  1y  2y  5y  max 
 Add ACL to Portfolio   Download Data

HEADLINES
A New Direction for Nestle?
Morningstar.com (Thu 6:03pm)
NovaBay Pharmaceuticals to Present at the Annual OneMedPlace Finance Forum
Marketwire (Thu 5:57pm)
UPDATE - Nestle CFO sees only small confectionery buys
at Reuters (Thu 12:04pm)
Alcon downgraded by UBS
Briefing.com (Thu 7:21am)
UBS downgrades Alcon, still expects higher offer
at MarketWatch (Thu 5:37am)
Novartis to Buy Aclon: Will the Gurus Sell?
at Seeking Alpha (Thu 3:57am)
The Alcon Independent Directors' Dilemma
at The New York Times (Wed, Jan 6)
Vasella's Persistence Pays Off for Novartis
at BusinessWeek (Wed, Jan 6)
Buffett Calls Strike 2 on Kraft
at Motley Fool (Wed, Jan 6)
Novartis May Raise Public Alcon Bid
at BusinessWeek (Wed, Jan 6)
Read the Novartis / Alcon Fine Print
at Seeking Alpha (Wed, Jan 6)
[$$] Nestlé Buys U.S. Pizza Lines
at The Wall Street Journal Online (Tue, Jan 5)
More Headlines for ACL...

ANALYST
EPS Est (next year) (Dec-09) : 6.71
EPS Est (in 2 years) (Dec-10) : 7.42
Avg Rec (current)*: 2.0
PEG Ratio: 1.79
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Alcon, Inc. engages in the development, manufacture, and marketing of pharmaceuticals, surgical equipment and devices, and consumer eye care products to treat primarily diseases and disorders of the eye in the United States and internationally.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News Canadian Indices